Loading…

Alternative Reagents for Methotrexate as Immobilizing Anchor Moieties in the Optimization of MASPIT: Synthesis and Biological Evaluation

We report the evaluation of two alternative chemical dimerizer approaches aimed at increasing the sensitivity of MASPIT, a three‐hybrid system that enables small‐molecule target protein profiling in intact human cells. To circumvent the potential limitations related to the binding of methotrexate (M...

Full description

Saved in:
Bibliographic Details
Published in:Chembiochem : a European journal of chemical biology 2015-03, Vol.16 (5), p.834-843
Main Authors: De Clercq, Dries J. H., Risseeuw, Martijn D. P., Karalic, Izet, De Smet, Anne-Sophie, Defever, Dieter, Tavernier, Jan, Lievens, Sam, Van Calenbergh, Serge
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report the evaluation of two alternative chemical dimerizer approaches aimed at increasing the sensitivity of MASPIT, a three‐hybrid system that enables small‐molecule target protein profiling in intact human cells. To circumvent the potential limitations related to the binding of methotrexate (MTX) to endogenous human dihydrofolate reductase (DHFR), we explored trimethoprim (TMP) as an alternative prokaryote‐specific DHFR ligand. MASPIT evaluation of TMP fusion compounds with tamoxifen, reversine, and simvastatin as model baits, resulted in dose–response curves shifted towards lower EC50 values than those of their MTX congeners. Furthermore, a scalable azido‐TMP reagent was synthesized that displayed a similar improvement in sensitivity, possibly owing to increased membrane permeability relative to the MTX anchor. Applying the SNAP‐tag approach to introduce a covalent bond into the system, on the other hand, produced an inferior readout than in the MTX‐ or TMP‐tag based assay. Cast the anchor: Two chemical dimerizer approaches, TMP‐ and SNAP‐tag, were evaluated so as to increase the sensitivity of a system that enables small‐molecule target protein profiling in intact human cells. Fusion compounds of tamoxifen tethered to a prokaryote‐specific DHFR ligand produced dose–response curves shifted towards significantly lower EC50 values than those of the original MTX congeners.
ISSN:1439-4227
1439-7633
DOI:10.1002/cbic.201402702